admin

Honor Technology, a growing force in the smartphone arena, has recently made headlines with the announcement of new investments that signal pivotal shifts in its growth trajectory. On Thursday, the company disclosed backing from several prominent investors, including China Telecom, a heavyweight in the telecommunications sector, and CICC Capital, alongside the venture capital firm Cornerstone
0 Comments
Eli Lilly’s recent third-quarter results reveal significant challenges as the pharmaceutical giant confronts a decline in both profit and revenue that fell short of analysts’ expectations. The company’s stock plummeted over 12% in early trading, a clear signal of investor discontent. This downturn was primarily driven by disappointing sales figures from its much-anticipated weight-loss medication,
0 Comments
In its latest financial report, Biogen has made headlines with third-quarter results that surpassed analysts’ expectations, primarily driven by its Alzheimer’s medication, Leqembi. Adjusted earnings are projected to land between $16.10 and $16.60 per share for the year, a noteworthy increase from the previously estimated range of $15.75 to $16.25 per share. However, despite this
0 Comments